Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

FHS
May 27, 2024
1:08 am

Researchers found that semaglutide treatment for weight loss in non-diabetic, obese men is associated with an increased risk of erectile dysfunction and testosterone deficiency.

Medeor’s cell therapy boosts immune tolerance in registrational trial of donor kidney recipients

Medeor Therapeutics’ Phase III single-dose cell therapy has seen more than half of a specific group of donor kidney recipients stop immunosuppression therapy for two

November 3, 2023

Microsoft Expands Healthcare AI Capabilities for Healthcare Orgs

What You Should Know: – Microsoft today announced enhanced Microsoft Cloud for Healthcare AI solutions and capabilities that support healthcare organizations in their journey toward

October 11, 2024

Opinion | A Tornado Ripping Through the Body: Streptococcal Toxic Shock Syndrome

Adalja is a practicing infectious disease, critical care, and emergency physician. The recent warning from Tokyo public health officials regarding the rising numbers of invasive

April 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.